Cyberounds Logo
December 12, 2018 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Evaluation and Treatment of Polycystic Ovary Syndrome
CME credit is no longer available for this conference.
Daniel A. Dumesic, M.D., Mark O. Goodarzi, M.D., Ph.D., Gregory D. Chazenbalk, Ph.D., David Geller, M.D., and David H. Abbott, Ph.D.

Dr. Dumesic is Professor and Division Chief of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of California Los Angeles; Dr. Goodarzi is Associate Professor, Director of Endocrinology, Diabetes, and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA; Dr. Chazenbalk is Associate Researcher, Department of Obstetrics and Gynecology, University of California Los Angeles; and Dr. Geller is Associate Professor of Pediatrics, Ahmanson Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, CA; and Dr. Abbott is Professor, Wisconsin National Primate Research Center and Department of Obstetrics and Gynecology, University of Wisconsin, Madison, WI.

Within the past 12 months Drs. Dumesic, Goodarzi, Chazenbalk and Geller report no commercial conflicts of interest; Dr. Abbott has received research grants from Boehringer-Ingelheim and Viamet, and been a consultant to Viamet.

Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.


Release Date: 02/21/2011
Termination Date: 02/14/2014

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Outline a metabolic evaluation for a woman with PCOS
  • Prepare ovulation induction for an anovulatory PCOS patient wishing to conceive
  • Describe a pubertal abnormality that can occur in PCOS adolescents
  • Discuss the pregnancy-related consequences of PCOS on maternal-fetal health.

 
The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity